Optimal duration of maintenance treatment with azathioprine in patients with inflammatory bowel disease

被引：0
|
作者：
Pica, Roberta
Avallone, Eleonoraveronica
Cassieri, Claudio
De Carolis, Aurora
Zippi, Maddalena
Vernia, Piero
Paoluzi, Paolo
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
AZATHIOPRINE; ULCERATIVE COLITIS; CROHN'S DISEASE; IBD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：805 / 805
页数：1
相关论文
共 50 条
  • [31] PREGNANCY IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS ON AZATHIOPRINE
    ALSTEAD, EM
    RITCHIE, J
    LENNARDJONES, J
    FARTHING, MJG
    CLARK, ML
    [J]. GUT, 1989, 30 (05) : A718 - A718
  • [32] Adverse effects of azathioprine in patients with inflammatory bowel disease (IBD)
    Ramirez de la Piscina, P.
    Estrada, S.
    Duca, I.
    Spicakova, K.
    Ganchegui, I.
    Calderon, M. D. R.
    Campos, A.
    Salvador, M.
    Delgado, E.
    Lopez Barbarin, J. M.
    Garcia Campos, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
  • [33] Optimal Interval for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Stable Infliximab Maintenance Treatment
    Hong, S. N.
    Yujin, L.
    Boram, P.
    Soon, J. Ok
    Ho, K. Young
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I745 - I745
  • [34] Duration of combination therapy and risk of treatment failure in patients with inflammatory bowel disease
    Lambrescak, Elsa
    Vaysse, Thibaut
    Allez, Matthieu
    Ungar, Bella
    Gleizes, Aude
    Hacein-Bey, Salima
    Chowers, Yehuda
    Roblin, Xavier
    Kopylov, Uri
    Rachas, Antoine
    Carbonnel, Franck
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [35] Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
    Campbell, S
    Ghosh, S
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (09) : 1073 - 1076
  • [36] Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease
    Achkar, JP
    Stevens, T
    Easley, K
    Brzezinski, A
    Seidner, D
    Lashner, B
    [J]. INFLAMMATORY BOWEL DISEASES, 2004, 10 (04) : 339 - 345
  • [37] Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naive to thiopurine treatment
    Alaish, Ram
    Lundgren, David
    Suhr, Ole B.
    Werner, Marten
    Karling, Pontus
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (07) : 594 - 600
  • [38] Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine
    Alexander, S
    Dowling, D
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (09)
  • [39] MTHFR polymorphisms are of pharmacogenetic value in azathioprine treatment in inflammatory bowel disease
    Ansari, A. R.
    Arenas, M.
    Marinaki, A.
    Duley, J.
    Greenfield, S.
    Lewis, C.
    Sanderson, J.
    [J]. GUT, 2007, 56 : A105 - A105
  • [40] The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease
    Glas, J
    Török, HP
    Daczo, J
    Tonenchi, L
    Folwaczny, M
    Folwaczny, C
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (12) : 535 - 538
12345